Citation Tools
PDFRegular and young investigator award abstracts
Combination immunotherapies
449 Neoadjuvant cyclic dinucleotides combined with interleukin-2 and anti-PD-1 antibody limit lung metastasis of orthotopic breast tumors through prolonged NK cell activation
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 449 Neoadjuvant cyclic dinucleotides combined with interleukin-2 and anti-PD-1 antibody limit lung metastasis of orthotopic breast tumors through prolonged NK cell activation